Administration of either anti-CD40 or interleukin-12 following lethal total body irradiation induces acute lethal toxicity affecting the gut

被引:8
作者
Hixon, JA
Anver, MR
Blazar, BR
Panoskaltsis-Mortari, A
Wiltrout, RH
Murphy, WJ
机构
[1] SAIC Frederick, NCI Frederick, Pathol Histotechnol Lab, Frederick, MD 21702 USA
[2] Univ Minnesota, Ctr Canc, Dept Pediat, Div Bone Marrow Transplantat, Minneapolis, MN USA
[3] NCI Frederick, Expt Immunol Lab, Frederick, MD USA
关键词
antibodies; transplantation; cytokines; in vivo animal models;
D O I
10.1016/S1083-8791(02)50029-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interleukin (IL)-12 and antibodies against CD40 have demonstrated antitumor effects in a variety of in vivo model systems. However, both agents can also mediate significant toxicities either when used following lethal TBI or when administered in combination with other agents such as IL-2. In this study, we assessed the effects of anti-CD40 monoclonal antibody (MoAb) and IL-12 in lethally irradiated mice. Acute lethal toxicity was observed following the administration of either 10 mug anti-CD40 MoAb (FGK45) or 0.5 mug of recombinant murine (rm)IL-12 that resulted in 100% mortality of all mice within 4 to 6 days. Histological evaluation revealed destruction of the normal gut architecture in both anti-CD40 MoAb- and rmIL-12-treated mice. Analysis of serum cytokine levels in the lethally irradiated mice receiving anti-CD40 MoAb demonstrated a marked increase of interferon (IFN)-gamma and IL-12 p40, whereas mice receiving rmIL-12 demonstrated a marked increase of IFN-gamma. Lethally irradiated IL-12 p40 knock-out mice were resistant to anti-CD40-induced toxicity, suggesting that the lack of IL-12 p40 with no possibility of making functional IL-12 p70 is key for this toxic reaction. Similarly, lethally irradiated IFN-gamma knock-out mice were completely resistant to rmIL-12-induced toxicity, suggesting that IFN-gamma is a major player in IL-12-mediated toxicity. These results suggest that both anti-CD40 MoAb and rmIL-12 induce an acute fatal toxicity characterized by similar intestinal pathology and mediated in part by IFN-gamma.
引用
收藏
页码:316 / 325
页数:10
相关论文
共 29 条
[1]   CD40 EXPRESSION BY HUMAN MONOCYTES - REGULATION BY CYTOKINES AND ACTIVATION OF MONOCYTES BY THE LIGAND FOR CD40 [J].
ALDERSON, MR ;
ARMITAGE, RJ ;
TOUGH, TW ;
STROCKBINE, L ;
FANSLOW, WC ;
SPRIGGS, MK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) :669-674
[2]   TUMOR-NECROSIS-FACTOR RECEPTOR SUPERFAMILY MEMBERS AND THEIR LIGANDS [J].
ARMITAGE, RJ .
CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (03) :407-413
[3]   THE CD40 ANTIGEN AND ITS LIGAND [J].
BANCHEREAU, J ;
BAZAN, F ;
BLANCHARD, D ;
BRIERE, F ;
GALIZZI, JP ;
VANKOOTEN, C ;
LIU, YJ ;
ROUSSET, F ;
SAELAND, S .
ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 :881-922
[4]   Interleukin-12: Murine models of a potent antitumor agent [J].
Brunda, MJ ;
Luistro, L ;
Rumennik, L ;
Wright, RB ;
Wigginton, JM ;
Wiltrout, RH ;
Hendrzak, JA ;
Palleroni, AV .
INERLEUKIN 12: CELLULAR AND MOLECULAR IMMUNOLOGY OF AN IMPORTANT REGULATORY CYTOKINE, 1996, 795 :266-274
[5]   Coadministration of interleukin-18 and interleukin-12 induces a fatal inflammatory response in mice:: critical role of natural killer cell interferon-γ production and STAT-mediated signal transduction [J].
Carson, WE ;
Dierksheide, JE ;
Jabbour, S ;
Angheina, M ;
Bouchard, P ;
Ku, G ;
Yu, HX ;
Baumann, H ;
Shah, MH ;
Cooper, MA ;
Durbin, J ;
Caligiuri, MA .
BLOOD, 2000, 96 (04) :1465-1473
[6]  
Carson WE, 1999, J IMMUNOL, V162, P4943
[7]   CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help [J].
French, RR ;
Chan, HTC ;
Tutt, AL ;
Glennie, MJ .
NATURE MEDICINE, 1999, 5 (05) :548-553
[8]   INHIBITION OF HUMAN B-CELL LYMPHOMA GROWTH BY CD40 STIMULATION [J].
FUNAKOSHI, S ;
LONGO, DL ;
BECKWITH, M ;
CONLEY, DK ;
TSARFATY, G ;
TSARFATY, I ;
ARMITAGE, RJ ;
FANSLOW, WC ;
SPRIGGS, MK ;
MURPHY, WJ .
BLOOD, 1994, 83 (10) :2787-2794
[9]   ANTIBODIES TO MURINE CD40 STIMULATE NORMAL B-LYMPHOCYTES BUT INHIBIT PROLIFERATION OF B LYMPHOMA-CELLS [J].
HEATH, AW ;
CHANG, R ;
HARADA, N ;
SANTOSARGUMEDO, L ;
GORDON, J ;
HANNUM, C ;
CAMPBELL, D ;
SHANAFELT, AB ;
CLARK, EA ;
TORRES, R ;
HOWARD, M .
CELLULAR IMMUNOLOGY, 1993, 152 (02) :468-480
[10]  
Hirano A, 1999, BLOOD, V93, P2999